概括
五年后冠状动脉疾病的进展对于接受慢性心痛治疗的医疗或手术治疗的患者来说是相似的. 最初的疾病状况显著影响进展风险,而移植与非移植的血管在手术患者中显示出相似的结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血管生物学 血管生物学
背景情况:
- 慢性胸痛影响了许多患者,需要有效的长期管理策略.
- 了解冠状动脉疾病 (CAD) 的进展对于优化治疗结果至关重要.
- 医疗和手术干预是稳定性胸痛的主要治疗方式.
研究的目的:
- 为了比较5年内冠状动脉疾病的进展,慢性心痛患者通过医疗治疗和手术治疗.
- 评估初始疾病状态和移植通透性对疾病进展的影响.
主要方法:
- 在大约65个月的医疗和手术治疗患者中,进行了重复血管造影.
- 冠状动脉被分析成部分和主要的干血管.
- 疾病进展被定义为新的阻塞 (> 50%) 或现有病变的恶化.
主要成果:
- 疾病进展的发生率在医疗 (22%的细分,63%的血管) 和手术 (23%的细分,63%的血管) 组之间是相似的.
- 最初没有疾病的部分有14%的进展率,而最初患病的部分有37% (p<0.001).
- 在手术患者中,移植的 (24%) 和非移植的 (22%) 分段表现出类似的进展;然而,通过主要的干部分析,移植的血管 (70%) 比非移植的血管 (51%) 有更高的进展.
结论:
- 冠状动脉疾病在稳定性心痛中的五年进展不受随机对医疗或手术治疗的影响.
- 最初没有疾病的血管在5年内患上新病变的风险较低.
- 在手术治疗的患者中,移植和非移植血管在细分水平上表现出可比的疾病进展率.
相关概念视频
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...


